Elutia prelim FY2024 net sales $24.4M, down 1% YoY; cardiovascular sales plunge 42%

ELUTIA INC.

Preliminary 2024 net sales $24.4M vs $24.7M in 2023, a 1% decline.
Women's health sales grew 12% to $11.6M; device protection up 5% to $9.9M.
Cardiovascular sales fell 42% to $2.9M, dragging overall results.
Results are preliminary; final numbers subject to adjustment upon completion of year-end close.
No further financial details provided; full 10-K to follow.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.